GSK buys efimosfermin alfa from Boston Pharma for USD 2 billion Ruchika Sharma9 July 2025 3:30 PM ISTLondon: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion deal.Efimosfermin is a...
Harsh V Trehan named CHRO, Executive Vice President at GSK India Ruchika Sharma7 July 2025 3:33 PM ISTMumbai: Harsh V. Trehan has been named as Chief Human Resources Officer (CHRO) and Executive Vice President at GSK India, Mumbai.In this new...
Bharat Biotech to cut malaria vaccine RTS.S price to under USD 5 for children in endemic countries Ruchika Sharma25 Jun 2025 2:54 PM ISTHyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and...
GSK application for expanded use of RSV vaccine in adults aged 18-49 accepted in Japan Ruchika Sharma22 Jun 2025 11:30 AM ISTGSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory application to expand the use...
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older Ruchika Sharma15 Jun 2025 10:00 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to expand the use...
Bharat Biotech to lead further development of GSK Shigella vaccine Ruchika Sharma12 Jun 2025 3:26 PM ISTHyderabad: Bharat Biotech International Limited has announced that it has partnered with GSK plc for the ongoing development and potential use of...
GSK Linerixibat application for cholestatic pruritus in primary biliary cholangitis patients under USFDA review Ruchika Sharma3 Jun 2025 2:15 PM ISTLondon: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ileal bile...
Phase 3 Trial Shows Promise for Oral Antibiotic Tebipenem pivoxil hydrobromide in Treating Complicated UTIs Dr. Kamal Kant Kohli30 May 2025 9:15 PM ISTTopline results from the phase 3 PIVOT-PO trial have revealed that tebipenem pivoxil hydrobromide (HBr), an investigational oral carbapenem...
FDA Approves Mepolizumab for Eosinophilic COPD Dr. Kamal Kant Kohli25 May 2025 9:15 PM ISTThe US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive pulmonary disease (COPD) in...
GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma Ruchika Sharma25 May 2025 1:30 PM ISTGSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of...
GSK Nucala wins USFDA OK for use in adults with COPD Ruchika Sharma23 May 2025 12:17 PM ISTLondon: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on maintenance treatment for...
GSK Blenrep combos win approval in Japan for multiple myeloma Ruchika Sharma20 May 2025 1:45 PM ISTGSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...
